• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Research on the Mechanism of Extra-mild Hypothermia(35℃) on neuronal cell death

Research Project

Project/Area Number 16590851
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Neurology
Research InstitutionNippon Medical School

Principal Investigator

KATAYAMA Yasuo  Nippon Medical School, Graduate School of Medicine, Professor, 大学院・医学研究科, 教授 (70152692)

Co-Investigator(Kenkyū-buntansha) KAMIYA Tatsushi  Nippon Medical School, Department of Medicine, Assistant Professor, 医学部, 講師 (70233955)
Project Period (FY) 2004 – 2005
Project Status Completed (Fiscal Year 2005)
Budget Amount *help
¥3,600,000 (Direct Cost: ¥3,600,000)
Fiscal Year 2005: ¥1,200,000 (Direct Cost: ¥1,200,000)
Fiscal Year 2004: ¥2,400,000 (Direct Cost: ¥2,400,000)
KeywordsHypothermia / Rat / Focal Ischemia / Apoptosis / Neuronal cell death / Immunocytochemistry / In situ hybridization / Rho-kinase / ERK / JNK
Research Abstract

The aim of this study is to determine whether a rho-kinase inhibitor, fasudil, would prevent neuronal cell death and whether a extra-mild hypothermia (35℃) would enhance the neuroprotective effects of the rho-kinase inhibitor, following transient focal ischemia in rats. Sprague-Dawley rats were subjected to MCAo using an intraluminal suture technique (Nito C et al, Brain Res 1008 : 179-185, 2004) for 2hrs. The rats were reperfused for 24hrs and decapitated for infarct and edema analysis. a rho-kinase inhibitor (fasudil)-treated animals received a continuous injection of fasudil (3.0 or 10.0mg/kg) for 1hrs by after the onset of ischemia, while vehicle-treated groups received same dose of vehicle. Edaravone- treated animals received a twice injection of edaravone at the dose of 3.0mg/kg just after the onset of recirculation and 30min after. During ischemia, temporal muscle and rectal temperatures were monitored and maintained at 37℃ in the treated animals. Animals were randomly divided i … More nto the following four groups (each, n=10) : (I) vehicle-treated group (control) ; (II) low dose fasudil-treated group (3.0mg/kg) ; (III) high dose fasudil-treated group (10.0mg/kg) ; (IV) edaravone-treated group (3.0mg/kg x 2). Temporal muscle and rectal temperatures were maintained during ischemia at 37 ± 0.2℃. Low dose fasudil (II) ameliorated the cortical and striatal ischemic damage compared with the control (I) significantly (p<0.05), whereas high dose fasudil (III) did not decreased the cortical and striatal infarct volume significantly compared with those of groups I and II (p<0.05). Furthermore, low dose fasudil (II) also decreased the cortical and striatal edema volume significantly compared with those of control (I). These results suggest that a rho-kinase inhibitor, fasudil, has a strong neuroprotective effect compared with edaravone that has already been applied clinically in Japan, and that this drug may be a new therapeutic neuroprotective agent for the treatment of acute stroke in clinical field. Less

Report

(3 results)
  • 2005 Annual Research Report   Final Research Report Summary
  • 2004 Annual Research Report

URL: 

Published: 2004-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi